Dose-response and system efficiency of pulmonary insulin in subjects with Type 1 diabetes

被引:0
|
作者
Balent, B
Brunner, GA
Sendlhofer, G
Ellmerer, M
Schaupp, L
Brandmair, H
Jendle, JH
Okikawa, J
Pieber, TR
机构
[1] Graz Univ, A-8010 Graz, Austria
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
[3] Aradigm Corp, Hayward, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
775
引用
收藏
页码:A202 / A202
页数:1
相关论文
共 50 条
  • [1] Dose-response of pulmonary insulin with the AERx® Insulin Diabetes Management System in healthy subjects
    Heise, T
    Scharling, B
    Bellaire, S
    Tusek, C
    Bott, S
    DIABETOLOGIA, 2001, 44 : A212 - A212
  • [2] Dose-response relationship of insulin glulisine in subjects with type 1 diabetes
    Becker, R. H. A.
    Frick, A. D.
    Teichert, L.
    Nosek, L.
    Heinemann, L.
    Rave, K.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 60 - 68
  • [3] Dose-response relationship of insulin glulisine in, subjects with type 1 diabetes
    Becker, Reinhard H. A.
    Frick, Annke D.
    Nosek, Leszek
    Heinemann, Lutz
    Rave, Klaus
    DIABETES CARE, 2007, 30 (10) : 2506 - 2507
  • [4] Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes
    Wutte, A
    Plank, J
    Sinner, F
    Druml, T
    Sommer, R
    Zdravkovic, M
    Ronn, BB
    Draeger, E
    Pieber, TR
    DIABETES, 2004, 53 : A152 - A152
  • [5] Linear dose-response relationship and early onset of action with inhaled human insulin using AERx® insulin Diabetes Management System in subjects with Type 1 diabetes
    Plank, J
    Wutte, A
    Bock, G
    Balent, B
    Midtgaard, A
    Ronn, BB
    Pieber, T
    DIABETOLOGIA, 2004, 47 : A313 - A313
  • [6] Insulin glulisine: dose response relationship in subjects with type 1 diabetes
    Nosek, L.
    Becker, R. H. A.
    Frick, A. D.
    Heinemann, L.
    Rave, K.
    DIABETOLOGIA, 2006, 49 : 621 - 621
  • [7] Linear dose-response relationship of inhaled human insulin using AERx® insulin diabetes management system (AERx® iDMS) and subcutaneous human insulin in subjects with type 1 diabetes
    Plank, J
    Balent, B
    Bock, G
    Wutte, A
    Midtgaard, A
    Ronn, BB
    Pieber, TR
    DIABETES, 2004, 53 : A113 - A113
  • [8] Dose-Response Effects of Insulin Glargine in Type 2 Diabetes
    Wang, Zhihui
    Hedrington, Maka S.
    Joy, Nino Gogitidze
    Briscoe, Vanessa J.
    Richardson, M. Antoinette
    Younk, Lisa
    Nicholson, Wendell
    Tate, Donna B.
    Davis, Stephen N.
    DIABETES CARE, 2010, 33 (07) : 1555 - 1560
  • [9] Comparison of pharmacodynamic and pharmacokinetic dose-response profiles between insulin detemir and NPH insulin in subjects with type 2 diabetes
    Pieber, TR
    Wutte, A
    Plank, J
    Bock, G
    Magnes, C
    Bodenlenz, M
    Endahl, L
    Draeger, E
    Jacobsen, LV
    DIABETES, 2004, 53 : A142 - A142
  • [10] Dose-response profile of acarbose in older subjects with type 2 diabetes
    Mooradian, AD
    Albert, SG
    Wittry, S
    Chehade, J
    Kim, J
    Bellrichard, B
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (05): : 334 - 337